The shocking story erupting over the last few days has been the DEA trying to classify all components of cannabis as a Schedule I substance. Specifically targeting cannabidiol (CBD), a compound that the UK calls a “medicine” and countless patients around the world use regularly to help a variety of symptoms. Schedule I drugs, substances, or chemicals are defined as drugs ... Continue Reading
DEA
Can DEA Curb the Surge in the CBD market?
Can the government really put the cannabis genie back in the bottle? This post from New Hope unravels how the federal agencies are heralding a new shift in the CBD market. Fifty years from now, historians may credit the Obama administration for legalizing marijuana by virtue of not standing in the way of states voting to legalize it. But the federal regulatory bodies are not ... Continue Reading
Why DEA Won’t Re-Schedule Cannabis
DEA won’t re-schedule cannabis right now, but is pushing for more research by FDA in order to do so in the near future. This post from Culture Magazine elaborates on how FDA is the real reason that DEA can’t re-schedule cannabis. There’s been a lot of media attention recently revolving around the Drug Enforcement Administration (DEA), which was rumored to be planning a ... Continue Reading
Marijuana Stays a Schedule I Controlled Substance
US affirms its prohibition on marijuana, keeping it on Schedule 1 list of controlled substances, however, this article from The Washington Post highlights that the DEA will allow more places to grow marijuana for research purposes. The government refused again Thursday to allow the use of marijuana for medical purposes, reaffirming its conclusion that the drug’s therapeutic ... Continue Reading
Report Blames DEA for Impeding Marijuana Research
A new report blasts DEA for spending four decades obstructing marijuana science. This article from The Huffington Post shares more details about the report! The Drug Enforcement Administration has been impeding and ignoring the science on marijuana and other drugs for more than four decades, according to a report released this week by the Drug Policy Alliance, a drug policy ... Continue Reading